The Latest Cardiac and Vascular News
VANCOUVER, July 16, 2018 /PRNewswire/ – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) announced today that, in connection with its new final short form base shelf prospectus (the “Base Shelf Prospectus”) filed with securities regulatory authorities in the provinces of British Columbia, Alberta, Saskatchewan, Manitoba and Ontario (the “Provinces”) and its corresponding shelf registration statement on Form […]
WAYNE, Pa.–(BUSINESS WIRE)–Cagent Vascular®, a developer of next generation angioplasty balloons using proprietary serration technology, announced the completion of $11.87 million in Series B funding. The round was led by two strategic investors including one that participated in the Series A financing. Additional participants included Balestier Investments, Ben Franklin Technology […]
FRANKLIN LAKES, N.J., July 12, 2018 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued its 2017 Sustainability Performance Update that focuses on four key strategic areas that support the company’s 2020 Sustainability Goals. BD’s sustainability strategy is driven by its purpose – advancing the world of health – and focuses on […]
IRVINE, Calif., July 12, 2018 /PRNewswire/ — Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, plans to announce its operating results for the quarter ended June 30, 2018 after the market closes on Thursday, July 26, 2018, and will host a conference call at 5:00 p.m. […]
REDWOOD CITY, Calif., July 12, 2018 (GLOBE NEWSWIRE) — Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that it has entered into a securities purchase agreement with certain institutional investors providing for the purchase and sale of 2,166,180 shares of common stock […]
EDEN PRAIRIE, Minn., July 12, 2018 (GLOBE NEWSWIRE) — CHF Solutions, Inc. (NASDAQ:CHFS), today announces it has entered into the German market by expanding a relationship with HSC-Medical, GmbH, a business solutions resource based in Germany. HSC-Medical will serve as a fulfillment house and logistical support for CHF Solutions, while the […]
MASON, Ohio–(BUSINESS WIRE)–AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that it will release its second quarter 2018 financial results on Wednesday, August 1, 2018. AtriCure will host a conference call at 4:30 p.m. Eastern Time on Wednesday, […]
July 11, 2018 11:45 AM Eastern Daylight Time PARIS–(BUSINESS WIRE)–Regulatory News: STENTYS (Paris:STNT) (FR0010949404 — STNT), a French group specialized in medical technologies for interventional cardiology, today reports its consolidated revenues and cash position at June 30, 2018. Christophe Lottin, Chief Executive Officer of STENTYS, comments: “The second quarter of 2018 notably […]
NEW YORK–(BUSINESS WIRE)–PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced that it has named Shaun M. O’Neil to serve as its first Chief Commercial Officer. Mr. O’Neil will oversee all aspects of the domestic and international commercialization of PAVmed’s products […]
WALTHAM, Mass.–(BUSINESS WIRE)–Corindus Vascular Robotics, Inc. (NYSE American:CVRS), a leading developer of precision vascular robotics, announced today that Aquilla “Quill” Turk, D.O. has joined the company as Chief Medical Officer, Neuroendovascular. Dr. Turk is a practicing physician at the Medical University of South Carolina where he serves as Director of […]
